DK0060615755
DK0060615755
Ascendis Pharma A/S
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 720.132.000 | 363.641.000 | 98.0% |
| Cost of Revenue | 94.915.000 | 44.258.000 | 114.5% |
| Gross Profit | 625.217.000 | 319.383.000 | 95.8% |
| 761.488.000 | 598.146.000 | 27.3% | |
| Operating Income | -136.271.000 | -278.763.000 | 51.1% |
| Pretax Income | -212.651.000 | -373.241.000 | 43.0% |
| Net Income Common Stockholders | -228.034.000 | -378.084.000 | 39.7% |
| -- | -- | -- | |
| -- | -- | -- |